This is one of the main reasons I’d like to see revenue ASAP. Not just for a higher pps but to get the cancer trials expanded and accelerated. We really do have an incredible molecule.

I also believe the oncology potential could mean BO talks are underway. (I know, I know, many don’t want a BO).